L3Harris (NYSE: LHX) CEO schedules stock and option sales under plan

Rhea-AI Filing Summary

L3Harris Technologies reported that Chairman and CEO Christopher Kubasik has established a written, pre-arranged trading plan under Rule 10b5-1 and the company’s insider trading policies.

The plan, set up during an open trading window, provides for the potential sale of vested options to purchase up to 129,501 shares granted in 2019 that expire in 2029, plus 60,000 shares of common stock. Sales, including shares underlying unexercised options, are scheduled on predetermined dates from May 2026 through no later than October 30, 2026, and are subject to minimum price thresholds specified in the plan.

The company notes that Mr. Kubasik’s ownership interest remains well above its stock ownership guidelines. Any transactions under the plan will be reported in Forms 4 and 144 filed with the SEC, and the company states it does not plan to routinely report other officers’ Rule 10b5-1 plans or changes to them outside of required periodic reports.

0000202058false00002020582026-02-042026-02-04

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 4, 2026

L3HARRIS TECHNOLOGIES, INC.

(Exact name of registrant as specified in its charter)

Delaware

1-3863

34-0276860

(State or other jurisdiction  of incorporation)

(Commission  File Number)

(I.R.S. Employer  Identification No.)

1025 West NASA Boulevard

Melbourne,

Florida

32919

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code: (321) 727-9100

No change

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, par value $1.00 per share

LHX

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.
Emerging growth company			☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.			☐

Item 8.01    Other Events.

On February 4, 2026, Christopher Kubasik, Chairman and Chief Executive Officer of L3Harris Technologies, Inc. (the “Company”), established a written pre-arranged plan adopted under Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, and the Company’s policies regarding transactions in the Company’s securities by executives (the “Plan”). The Plan was established during the Company’s open trading window. In accordance with Rule 10b5-1, Mr. Kubasik will have no discretion over sales under the Plan.

The Plan covers vested options to purchase up to 129,501 shares granted to Mr. Kubasik in 2019, which options expire in 2029, and 60,000 shares of common stock. Subject to minimum price thresholds specified in the Plan, shares, including shares underlying unexercised options, will be sold on predetermined dates starting in May of 2026 and ending no later than October 30, 2026. Mr. Kubasik’s ownership interest in the Company is considerably in excess of the Company’s stock ownership guidelines. Transactions under the Plan will be disclosed publicly through Form 4 and Form 144 filings, as applicable, with the U.S. Securities and Exchange Commission.

Except as may be required in the Company’s periodic filings on Form 10-Q or Form 10-K, the Company does not undertake to report any Rule 10b5-1 plans that may be adopted by any other officers or directors of the Company or to report modifications or termination of any such plans, including the Plan.

Item 9.01 Financial Statements and Exhibits.

     (d) Exhibits.

 The following exhibits are provided herewith:

Exhibit Number			Description
104			Cover Page Interactive Data File formatted in Inline XBRL

1

SIGNATURE

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

L3HARRIS TECHNOLOGIES, INC.

By:

/s/ Christoph T. Feddersen

Name:

Christoph T. Feddersen

Date: February 6, 2026

Title:

Sr. Vice President, General Counsel and Secretary

2

FAQ

What did L3Harris (LHX) disclose about its CEO in this 8-K?

L3Harris disclosed that CEO Christopher Kubasik adopted a written Rule 10b5-1 trading plan. The plan pre-arranges future sales of stock and options under company policies, executed without his discretion once it is in effect.

How many L3Harris (LHX) shares are covered by Christopher Kubasik’s plan?

The plan covers vested options to purchase up to 129,501 shares granted in 2019 and 60,000 shares of common stock. These amounts define the maximum potential shares involved in scheduled sales under the Rule 10b5-1 plan.

When will sales under the L3Harris (LHX) CEO’s 10b5-1 plan occur?

Sales under the plan are scheduled on predetermined dates starting in May 2026 and ending no later than October 30, 2026. Transactions must also meet minimum price thresholds specified in the plan before any sale occurs.

Does Christopher Kubasik retain a significant ownership stake in L3Harris (LHX)?

Yes. L3Harris states that Christopher Kubasik’s ownership interest remains considerably above the company’s stock ownership guidelines. This indicates he will continue to hold a substantial stake even while sales occur under the Rule 10b5-1 plan.

Will L3Harris (LHX) report other executives’ Rule 10b5-1 trading plans?

L3Harris states it does not undertake to report Rule 10b5-1 plans adopted by other officers or directors, or any modifications or terminations. Disclosure would occur only as required in periodic reports such as Form 10-Q or Form 10-K.

How will investors see transactions from the L3Harris (LHX) CEO’s plan?

Transactions under the CEO’s Rule 10b5-1 plan will be disclosed in Forms 4 and 144 filed with the U.S. Securities and Exchange Commission. These forms will show actual executed sales as they occur under the plan’s terms.